Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...

This license enables Vaxxas to prepare for a clinical trial of the first Respiratory Syncytial Virus (RSV) vaccine delivered to the skin using Vaxxas’ novel high-density microarray patch (HD-MAP).

Respiratory syncytial virus (RSV) is a negative-stranded ... of broadly neutralizing antibodies following vaccination, most vaccine developers are not pursuing the G protein as a component ...

As Mississippi approaches what is historically the respiratory virus season, the Mississippi State Department of Health (MSDH ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV ... There are RSV vaccines for older adults and pregnant people.

Also Read: Pfizer’s Respiratory Syncytial Virus Vaccine Data Shows Promise In Subgroup Of Younger Immunocompromised Patients. The company intends to submit MONeT results for publication in a ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that the United States National Institutes of ...